$1.20
-0.04 (-3.23%)
Open$1.23
Previous Close$1.24
Day High$1.23
Day Low$1.19
52W High$3.31
52W Low$0.76
Volume—
Avg Volume1.17M
Market Cap96.47M
P/E Ratio—
EPS$-0.59
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+800.8% upside
Current
$1.20
$1.20
Target
$10.81
$10.81
$7.63
$10.81 avg
$13.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 692.4K | 602.1K | 16.05M |
| Net Income | -53,367,541 | -41,769,533 | -3,462,613 |
| Profit Margin | -7,732.0% | -7,345.4% | -21.6% |
| EBITDA | -56,557,146 | -46,725,183 | -3,307,317 |
| Free Cash Flow | — | — | -2,137,974 |
| Rev Growth | +15.0% | +15.0% | +0.8% |
| Debt/Equity | — | — | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |